Abstract: African Americans experience poorer diabetes outcomes than non-Hispanic Whites. Few clinical trials of diabetes self-management interventions specifi cally target African Americans, perhaps due to well-documented barriers to recruitment in this population. This paper describes strategies used to successfully recruit 211 low-income African Americans from community clinics of a large, urban public hospital system to a randomized clinical trial of an 18-month diabetes self-management intervention. Diabetes-related physiological, psychosocial, and behavioral characteristics of the sample are reported. The sample was 77% female, mean age = 55, mean A1C = 8.5%, 39% low health literacy, 28.4% moderate/severe depression, and 48.3% low adherence. Participants ate a high-fat diet with low vegetable consumption. Relative to males, females had higher BMI, depression, and stress, and better glycemic control, less physical activity, and less alcohol consumption. Males consumed more daily calories, but females consumed a greater proportion of carbohydrates. Gender-specifi c diabetes self-management strategies may be warranted in this population.
trol among African Americans. 9, 10 Although T2DM can be eff ectively managed with medication, diet, and exercise, 11, 12 individuals of lower socioeconomic status who live in disadvantaged neighborhoods face signifi cant challenges in adhering to recommended diabetes self-care practices. 13 Failure to attain glycemic control increases the risk of heart disease, stroke, vision loss, renal failure, and neuropathy. [14] [15] [16] Diabetes self-management interventions have been successful at improving glycemic control among individuals with T2DM, at least in the short-term. 17 However, despite serious disparities in T2DM prevalence and outcomes, the majority of T2DM self-management interventions have been conducted with non-Hispanic Whites. 17, 18 This is not unique to T2DM self-management interventions: African Americans are under-represented in clinical trials across a range of diseases and interventions. 19, 20 In order to reduce Black-White disparities in T2DM and other diseases, it is critical to increase representation of African Americans in clinical trials.
An extensive body of literature documents barriers to clinical trial participation for African Americans. [21] [22] [23] [24] A number of studies indicate that African Americans perceive that research will benefi t Whites only, or the medical institution, rather than benefi tting communities of color. 20, [25] [26] [27] [28] Other barriers to participation include distrust of the medical system based on personal experience of poor quality of care, 20, 29, 30 the time commitment necessary to participate, 26, 31, 32 and concern about potential side eff ects of the intervention. 26, 27, 32 An additional barrier is a negative view of randomization and a desire to avoid being assigned to a control group in a trial. 28 Suggested strategies to address these barriers include assuring cultural congruence among participants and research staff , providing adequate and appropriate information about the purpose of the study, focusing on altruism as motivation for participation (e.g., how participation could benefi t the community and future generations), and increasing the convenience of participation (e.g., covering transportation cost). 26 Recruitment from community clinics may facilitate enrollment of African American patients because clinic staff are more familiar and therefore potentially more trustworthy to patients. 32 However, signifi cant barriers to research participation exist on the part of community clinics. 33 The most signifi cant barrier is the lack of suffi cient staff time to participate in the research, and concern about loss of productivity and income due to participation in research activities. 34 Recommended strategies to address these barriers involve creation of a collaborative research environment by assessment of resources and needs of the clinics, and establishment of clear expectations. 33, 35 This paper describes strategies that led to the successful recruitment of urban, lowincome African American adults with uncontrolled T2DM for the Lifestyle Improvement through Food and Exercise (LIFE) study. The LIFE study was a randomized controlled trial that evaluated the eff ectiveness of an 18-month community-based culturally-tailored intervention that was designed to help low-income urban African American adults with T2DM improve glycemic control via diet, exercise, and self-management skills. Participants were recruited from community clinics of the Cook County Health and Hospital System (CCHHS), one of the largest safety-net public hospital systems in the United States. We also report on the physical, behavioral, and psychosocial baseline characteristics of the study sample. Understanding disease-specifi c, behavioral, and psychosocial characteristics of low-income African Americans with T2DM will facilitate identifi cation of factors that contribute to health disparities. Further, understanding characteristics of this high-risk population is necessary to inform development of appropriately tailored interventions. 36 
Methods
Intervention. The LIFE study was designed to compare the eff ectiveness of culturallytailored group-based self-management sessions and telephonic peer support with standard of care diabetes self-management education. The intervention consisted of 28 group sessions over 12 months, and two maintenance sessions over the subsequent six months. The control arm consisted of two sessions in the fi rst six months. The target enrollment for the study was 210 participants, with 105 per treatment arm. Participants randomized to the intervention arm were assigned to one of six self-management groups of 15-20 participants. Groups were organized by clinic-all participants who attended the same group were from the same clinic.
Partnership with community health system. Study participants were patients of the CCHHS outpatient community clinics. The CCHHS is the public safety-net hospital system covering Cook County, Illinois and has one of the highest volumes of annual outpatient diabetes visits in the country. 37 Formal partnerships were created between Rush University Medical Center (RUMC), the academic research institution leading the research, and two entities of the CCHHS. First, a partnership was established with the Ambulatory and Community Health Network (ACHN), which coordinates community clinics for the CCHHS throughout Cook County, Illinois. Funding was provided from RUMC via subcontract to the ACHN for staff time and for incentives to clinics for participation in the study. The ACHN provided space in the clinics for study research assistants (RAs) to recruit patients and conduct all patient assessments for the study.
A second partnership, also funded through a subcontract, was established with the Division of Endocrinology, Diabetes and Metabolism within the CCHHS Department of Medicine. The Division chair served as a co-Investigator and Medical Director on the study, and a Division dietitian served on the intervention team. The ACHN worked with the Division to identify potentially eligible patients.
Eligibility criteria. Eligibility criteria were designed to be as inclusive as possible to maximize the generalizability of results while assuring that patients were healthy enough to safely benefi t from the lifestyle intervention. Inclusion criteria included a diagnosis of type 2 diabetes mellitus, uncontrolled diabetes (A1C ≥ 7.0%), African American race, age 18 or older, and seen at least once in the past 12 months by a primary care physician in a designated CCHHS primary care clinic. Participants were required to be available at the time the group sessions were scheduled. Intervention and control group sessions were held at the same day and time.
Exclusion criteria included BMI < 18.5 kg/m2, end-stage renal disease (glomerular fi ltration rate [GFR]<15 mL/min/1.73 m2), stroke with paresis, congestive heart failure (New York Heart Association class 2-4) or major end-organ complications of diabetes, conditions limiting future life expectancy to less than four years, current pregnancy, diagnosis of a major psychiatric condition, use of prednisone ("steroids") in the prior three months, weight loss surgery, lack of access to telephone, inability to walk two blocks without stopping, impaired cognitive function, not cleared for participation by a primary care physician, or living in the same household as an active study participant. Medical questions related to eligibility and participant safety were adjudicated by the study endocrinologist.
Recruitment. Participants were recruited from fi ve outpatient community clinics within the CCHHS. The fi ve recruitment clinics were those that had the largest population of African Americans in the CCHHS ACHN. Four of the clinics were in Chicago and had predominantly African American patient populations, and one clinic was located in a suburb south of Chicago and had a patient population of mixed race and ethnicity. Of the four urban clinics, three were located in high-poverty, highsegregation neighborhoods and the fourth was located in a neighborhood undergoing rapid gentrifi cation. The suburban clinic was located in a neighborhood undergoing gradual racial/ethnic integration.
The staged recruitment process included: (1) a medical record review, (2) a prescreening interview, (3) information session and screening visit, and (4) two baseline assessment visits and (5) randomization. The study was approved by the institutional review boards at Rush University Medical Center and CCHHS.
Medical record review. Staff of the ACHN identifi ed adult patients who were 18 years of age or older with clinically diagnosed T2DM, A1C ≥ 6.5%, and seen at one of the recruitment clinics during the prior calendar year. Staff of the CCHHS Division of Endocrinology, Diabetes and Metabolism reviewed medical records of each of these patients. Patients were considered potentially eligible if they were African American, able to perform daily activities, and had type 2 diabetes based on type of diabetes medications and diagnosis in the clinical notes. They were also required to have GFR > 15 ml/min. Lists of potentially eligible patients were sent to RUMC study staff , along with dates and times of scheduled clinic appointments.
Prescreening interview. Research assistants (RAs) who were involved in recruitment were African American and both came from communities similar to those of study participants. Research assistants worked from offi ces within the clinics. RAs contacted patients, either in the clinic waiting room or by telephone, to conduct a prescreening interview. When recruiting by phone, RAs called patients from the clinic telephone so the number on the caller ID was familiar to the patients, and described the study as a collaborative eff ort between the clinic and RUMC. The objectives of the prescreening interview were 1) to describe the study to patients, 2) to assess interest in and availability to participate, and 3) to collect further information about health status to ensure eligibility. Eligible and interested patients were invited to a group information session at the clinic to learn more about the study. The information session also served as the fi nal screening visit.
The study required that intervention participants be assigned to six groups of 15-20 people (to meet the intervention arm enrollment target of 105 participants). To achieve this within a randomized design, recruitment took place in six waves. Within each recruitment wave, eligible patients were not invited to the information session until at least 30-40 patients were identifi ed as willing and able to attend the classes. Within each wave, participants were randomly assigned to either the intervention or control group in a 1:1 ratio so that approximately 20 patients would be assigned to each. We used a blocked randomization scheme supervised by the study statistician, alternating block sizes of four and six to ensure equal allocation to the two groups. Two recruitment waves were completed at one clinic and the remaining four recruitment waves were completed at four separate clinics. This recruitment process required that some participants wait a number of months before enrollment.
Information session and screening visit. The information session was conducted by RAs and an intervention staff member who was African American and from a similar community as participants. At the information session, study staff explained the rationale and the goals of the study and requirements for participation. Study staff described a number of potential cons of the study, including: 1) participants could not control the treatment arm to which they would be assigned, 2) one treatment arm would require an extensive time commitment (30 two-hour group sessions over 18 months), and 3) participants would be asked to participate in four extensive assessments over 18-months. Potential benefi ts were also described to participants, including: 1) they would receive education on how to care for their diabetes, and 2) their participation would help doctors better understand how to help African Americans manage their diabetes and, therefore, potentially help reduce disparities in diabetes outcomes. Patients were also informed that they would receive $10 per group session and remuneration for in-person assessments ($100 for three long assessments consisting of two visits and wearing the accelerometer for a week, and $25 for one short assessment) in order to address transportation and other costs of participation. Patients were asked to discuss pros and cons of participation amongst themselves and share any questions or concerns with study staff . 38 At the end of the information session, interested patients completed the informed consent process and were given a Point-of-Care A1C test. If A1C was ≥7.0%, RAs scheduled patients for a baseline assessment visit at the primary care clinic.
Baseline assessment visits and randomization. All participants were required to complete two assessment visits prior to enrollment. At the fi rst visit, participants completed a 24-hour food recall, anthropomorphic measures, various questionnaires, and were given an accelerometer to wear for a week. All patients returned to the clinic approximately one week later to return the accelerometer and complete a second 24-hour food recall. Aft er the second visit, patients were paid a cash incentive for completing the assessment process. Patients were enrolled in the study aft er completing both visits and randomized.
Measures. All assessments were conducted at the patients' primary care clinic by study RAs blinded to participant group assignment. A1C point of care was measured using capillary blood samples collected via fi nger stick. Blood pressure was measured with patient sitting using an Omron Digital Blood Pressure Monitor (Omron Healthcare, Inc. Lake Forest, Illinois) which averaged three readings taken over a 10-minute period. Dietary intake was measured using two in person 24-hour dietary recalls using the Nutrition Data System for Research soft ware (Nutrition Coordinating Center, University of Minnesota, Minneapolis, Minnesota). The soft ware uses the multiple-pass interview method and data collection is standardized by built-in soft ware interview prompts. Physical activity was measured using an accelerometer worn around the hip or waist. Participants were asked to wear the device for seven days for at least 10 hours per day. Sedentary behavior was defi ned as the number of minutes out of the fi rst 10 hours of valid wear time (which included waking hours only) in which accelerometerderived vector magnitude counts ≤200. 39 Daily minutes of moderate intensity activity was calculated by summing all minutes of moderate intensity activity per day. All outcome measures are listed in Box 1.* Additional details about study data collection procedures, variables and statistical analysis are described elsewhere. 40 
Results
Recruitment. Recruitment began in March 2012 and was completed by April 2014. Figure 1 presents a consort diagram of the recruitment process. Based on medical record review, CCHHS identifi ed 3,048 patients who met initial screening criteria. Study staff attempted to contact 2,797 (92%) of the potentially eligible patients. Patients were not contacted when recruitment goals for their clinic had been met. Of the patients attempted, RAs were unable to reach 1,394 (49.8%) of the prescreened patients aft er three attempts or because the telephone number was disconnected. Of the 1,403 patients who were successfully contacted, 822 (58.6%) agreed to be screened and 603 of the screened patients (73.3%) met eligibility criteria and agreed to attend information sessions. Of those who agreed to attend the information session, 269 (44.6%) attended, and a majority of those (n = 254, 94%) chose to participate and provided consent. Of those, 43 patients were excluded due to point-of care A1C < 7%. The remaining 211 participants completed baseline assessments and were randomized into the study.
Baseline characteristics. The baseline demographic and clinical characteristics of the total sample of randomized participants are presented in Tables 1 and 2 . Participants were African American adults whose average age at randomization was 55 years old. A majority of the participants were female (70.1%) and single (51.7%) and had an annual household income less than $40,000 (90.5%), and 54% completed some college. Most participants were unemployed (34.1%) or retired (22.8%), and were uninsured (65.4%). Physical, behavioral, and psychosocial baseline characteristics for the entire sample are presented in Table 3 . Participants had high rates of obesity (70.1%) and a majority had hypertension (91%). Virtually all participants (97.6%) reported use of insulin and/or oral medication and 48.3% reported low medication adherence. Participants consumed higher than recommended amounts of total fat (37.9% of daily calories) and saturated fat (11.3%) and fewer vegetable servings than recommended (1.1 servings/day). 41, 42 The sample had low rates of physical activity-71% of the accelerometer minutes were classifi ed as sedentary for both males and females. Finally, 28.4% of the sample reported experiencing moderate to severe depression over the prior two weeks.
Gender diff erences in baseline characteristics. There were no diff erences between females and males on age, income, education, marital status, employment status, or insurance status (see Table 1 ). Males had higher A1C values (9.2 vs 8.3, p = .006) and *Box 1 includes citations. Those citations appear along with all the other references at the end of this paper. The numbering of the citations in the box starts where the numbering of the citation in the whole text ends (i.e., it starts with #50).
Box 1.

LIST OF MEASURES USED IN THE LIFESTYLE IMPROVEMENT THROUGH FOOD AND EXERCISE LIFE STUDY Demographic Characteristics
Measures
Participant demographic information Self-reported demographic questionnaires, which included questions about income, education, employment and insurance.
Physical Characteristics
Measures
Glycemic control Hemoglobin A1c levels. Blood samples were collected via fi nger stick and processed through the Axis-Shield Afi nion A1CPOC device. 50 Blood The accelerometer data were scored using PC-SAS (SAS Institute Inc., Cary, NC) version 9.2, partly using sample codes from NHANES accelerometer data analysis (http://riskfactor. cancer.gov/tools/nhanes_pam).
Perceived social support Support received subscale from Diabetes Care Profi le [54] [55] [56] Diabetes-specifi c quality of life Social and Personal Factors subscale from Diabetes Care Profi le [54] [55] [56] Self-effi cacy Self-care ability subscale from Diabetes Care Profi le [54] [55] [56] Diabetes self-care behaviors The Summary of Diabetes Self-Care Activities Measure (Table 2) . Gender diff erences in behavioral and psychosocial factors were also noteworthy (see Table 3 ). Males were more than twice as likely to report consumption of two or more alcoholic drinks weekly, but females endorsed more depression, more stressful events in the past year, and a greater number of PTSD symptoms, as well as higher levels of religiosity, than males (see Table 3 ). Women had greater diabetes-related nutrition knowledge than did men (35 vs. 32, p = .029) and men reported a greater number of days meeting physical activity goals (2.5 versus 1.5 days per week, p = .029).
Discussion
Recruitment for this study included a number of strategies to address barriers to participation for both participants and community clinics. Use of these strategies resulted in successful and timely achievement of recruitment targets for an 18-month randomized controlled trial within the allotted two-year recruitment time period. A number of strategies were utilized in order to address the well-documented distrust experienced by African Americans regarding medical research. First, all recruitment, both in-person and telephonic, was conducted from the patients' own clinic (i.e., the telephone number on caller ID was familiar to patients as it came from the clinic), and all assessment visits were conducted at the clinic. Second, all recruitment staff were African Americans who were culturally similar to participants. Third, participants were provided extensive information about the study prior to being asked to consent, including pros and cons of participation, and were invited to discuss pros and cons amongst themselves. Fourth, participants were provided fi nancial assistance to cover transportation and other costs of participation, including payment for their time during the assessment visits.
Recruitment was facilitated by a successful partnership arrangement between the researchers and the community clinics and the Division of Endocrinology in the Department of Medicine at CCHHS. Literature suggests that concerns about the costs of participation can serve as a barrier to participating in research for community clinics. This barrier was addressed through a partnership agreement which defi ned expectations of each CCHHS entity and specifi ed the costs of any services provided by the CCHHS. The ACHN was remunerated for clinic space for the RAs, potential costs of physician time to provide permission for patients to participate and additional patient visits that might be required to address changes in medication due to improved glycemic control from lifestyle changes of participating patients, and fi nally, for ACHN .004
Body mass index categories, n (%)
.073 .023
Frequency of self-reported hypoglycemic incidents, n (%)
. e Diabetic complications and comorbidities include history of hypertension, dialysis, heart attack or myocardial infarction, heart failure, stroke, renal insuffi ciency, dialysis, diabetes related eye-damage, 4+ hypoglycemic incidents per month.
f History of cancer, arthritis, lung, cirrhosis or liver disease, depression, asthma, sleep apnea, neurological diseases, HIV or AIDs, serious mental illness.
g Although the two groups have equal medians, Wilcoxon test showing statistically signifi cant gender diff erences because the ranges diff er between men and women with women reaching a higher number of chronic conditions. Table 3 . .478
BEHAVIORAL CHARACTERISTICS DIET, EXERCISE, SUBSTANCE USE, PSYCHOSOCIAL OF PARTICIPANTS IN THE LIFESTYLE IMPROVEMENT THROUGH FOOD AND EXERCISE LIFE STUDY
Percent kcal from trans fat . .477
Alcohol beverages consumed in past year, n (%)
. .007 a n = 210 for dietary variables.
b
Wilcoxon used for comparing non-normal data, Chi-square used for categorical data, t-tests used for normally distributed continuous data. Higher scores indicate higher levels of perceived stress.
q Perceived Discrimination Scale, 10 items, response format: range 1-4 (never to oft en).
Higher scores indicate higher levels of perceived discrimination.
r Items from the Daily Spiritual Experiences Scale, 4 items, response format: range 1-6 (many times a day to once a year or less).
Higher scores indicate higher levels of religiosity. staff time to identify eligible patients and to problem-solve issues that arose among clinic staff . Division of Endocrine staff participated as paid members of the research and intervention teams and Division staff were compensated for medical record screening of potential participants. These strategies resulted in a collaborative partnership in which key CCHHS staff participated as equal members of the research team.
Characteristics of patients in this study suggest a need for tailoring of interventions to address the distinct needs of African American men and women. While both men and women could benefi t from interventions to improved diet and exercise, women may especially benefi t from interventions to manage depression and increase physical activity. In the LIFE sample, female participants endorsed higher rates of depression and stress compared to males. Given the association between depression and increased risk of diabetes complications, 43 and mortality, 44 mood could be an important target for further tailoring of the intervention for women. 45 In contrast, interventions focused on men may need to address higher rates of alcohol use. In fact, men may be more likely to be excluded from trials due to excessive use of alcohol as an exclusion criterion. 29 Finally, men and women appear to have distinct dietary patterns, suggesting a potential need for tailoring of nutrition education.
The diff erences between males and females extended also to BMI and glycemic control. Males had signifi cantly lower BMI and worse glycemic control; half of the males had very poor glycemic control (A1c ≥ 9%). This may be counterintuitive because obesity is known to increase insulin resistance. The fact that males who were less obese had worse glycemic control may be explained by poorer self-management in males or by worse beta cell function. In a study conducted in a similar population it was suggested that lean males with diabetes may have accelerated decline of beta cell function associated with higher rate of alcohol consumption and smoking. 46 Study limitations. A limitation of the recruitment process was that we were more successful recruiting females than males. As in many studies with African Americans, men are under-represented in our study. 47 As indicated by our baseline data, men and women in our target population diff ered on a number of important clinical, behavioral, and psychosocial characteristics. Most of the men who enrolled in the study came from one clinic which had a special sub-clinic for African American men, staff ed primarily by African American male physicians. Staff of this program worked with us to facilitate recruitment of men in that clinic. This suggests that recruitment of African American males may require additional strategies, including the use of African American male research staff and recruitment materials specifi cally targeting males. 47 Further research is needed to address underrepresentation of African American males in clinical trials.
In sum, strategies described here resulted in successful recruitment of low-income patients living in a range of urban areas, including highly segregated and impoverished neighborhoods. Recruitment results and characteristics of participants diff ered by gender, indicating that gender-specifi c intervention studies may be warranted in this population. Minority and lower socioeconomic status are associated with higher prevalence of T2DM, poorer T2DM clinical outcomes, higher rates of T2DM complications, and mortality. 48, 49 Inclusion of these individuals in a T2DM self-management intervention is challenging, but critical in order to increase knowledge about how best to address poor glycemic control among disadvantaged African Americans and reduce disparities in T2DM outcomes.
